{"cdcTestId":"2013-0262","testcaseName":"dose 3 to 4 Pediarix, interval 4 mo-1 day","vaccineGroup":"HepB","evaluationTestType":"All Valid: Forecast Test","forecastTestType":"Not recommended: series complete","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2021-08-19T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Complete","administeredDoses":[{"dateAdministered":"2021-10-19T00:00:00","vaccineName":"PEDIARIX","cvx":"110","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2021-12-19T00:00:00","vaccineName":"PEDIARIX","cvx":"110","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-06-19T00:00:00","vaccineName":"PEDIARIX","cvx":"110","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-18T00:00:00","vaccineName":"PEDIARIX","cvx":"110","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"-","earliestDate":"0001-01-01T00:00:00","recommendedDate":"0001-01-01T00:00:00","pastDueDate":"0001-01-01T00:00:00"},"doses":[{"dateAdministered":"2021-10-19T00:00:00","vaccineName":"PEDIARIX","cvx":"110","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2021-12-19T00:00:00","vaccineName":"PEDIARIX","cvx":"110","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-06-19T00:00:00","vaccineName":"PEDIARIX","cvx":"110","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-18T00:00:00","vaccineName":"PEDIARIX","cvx":"110","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2022-01-11T07:03:04.181","generalDescription":"This test case describes when a fourth dose of the HepB vaccine is administered at an interval of 4 months - 1 day from dose 3, that the dose is considered to be valid. The series is complete.","changedInVersion":"4.18","reasonForChange":"v4.18  Updated fourth dose Evaluation Status from \u0022Extraneous\u0022 to \u0022Valid\u0022. ACIP acknowledges a 4 dose HepB series and this dose fits that series."}